Watts Ryan J. bought DNLI
January 3, 2026 · Form 4 insider transaction
Watts Ryan J. bought 78,960 shares of Denali Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
78,960
Price
$0.00
Total value
N/A
InsiderWatts Ryan J.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 3, 2026
Filing dateJanuary 5, 2026
Shares owned after332,031
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2027 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.; Includes 184,915 Unvested RSUs.